| Not a member? Join now!
This symposium will highlight state-of-the-art technologies in protein and antibody engineering, and antibody-drug conjugates. The implementation of these methods to specific diseases, and unique research tools, will also be discussed.
Chemical Biology is changing the face of drug discovery. This symposium will highlight recent developments in the field, featuring examples from neurobiology and cancer, the ubiquitin proteasome system, GPCRs, and protein lipidation.
It's easier to find people to invest in a great new tech product if you can show that it will be profitable relatively quickly. Unfortunately, that's not so easy to demonstrate. Learn how we're working to change that.